Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status

Petros Grivas, Elizabeth R. Plimack, Arjun V. Balar, Daniel Castellano, Peter H. O'Donnell, Joaquim Bellmunt, Thomas Powles, Noah M. Hahn, Ronald de Wit, Dean F. Bajorin, Misoo C. Ellison, Tara L. Frenkl, James L. Godwin, Jacqueline Vuky

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status'. Together they form a unique fingerprint.

Medicine & Life Sciences